Cervical cancer lesions represent a major threat to the health of the women worldwide. Human Papillomavirus (HPV) is responsible for 99.7% of cervical cancer cases, the infectious etiology giving the possibility of preventing cervical cancer by vaccination. The most aggressive HPV types are 16 and 18, which cause about 70% of cases of invasive cancer. The vaccination is recommended to the girls...

Invasive cervical cancer still represents one of the major issues of preventive oncology either in developed countries or in developing countries, accounting for the fourth leading cause of cancer related deaths in women worldwide and the second leading cause of deaths in women in developing countries [1]. It is the greatest cause of cancer death in women in sub saharan Africa, even outstrippin...

OBJECTIVES To determine the effect of the HIV epidemic on invasive cervical cancer in Kenya. METHODS Of the 3902 women who were diagnosed with reproductive tract malignancies at Kenyatta National Hospital (KNH) from 1989 to 1998, 85% had invasive cervical cancer. Age at presentation and severity of cervical cancer were studied for a 9-year period when national HIV prevalence went from 5% to 5...

DISCLOSURE: None ABSTRACT Background: This study is the first population based cancer incidence report from a cancer registry in south-east Nigeria. Objective: To evaluate the incidence of some invasive cancers in southeast Nigeria. Methodology: We collected all new cases of invasive cancers between 1st January and 31st December, 2013. We computed the age standardized incidence rate (ASRs) for ...

In the United States, cervical cancer screening programs based on exfoliated cervical cytology (Pap smears) have significantly reduced the incidence of invasive cervical cancer. As a result of this success, current cervical cancer screening programs in the US are not directed at invasive disease, but at detection of the precursors of carcinoma, referred to as dysplasias, squamous intraepithelia...

references 1. juckett g, hartman-adams h. human papillomavirus: clinical manifestations and prevention. american family physician. 2010; 82(10): 1209-14. 2. world health organization. human papillomavirus infection and cervical cancer, 2012. [http://www.who.int/gho/publications/world_health_statis tics/en_whs2012_full.pdf ] 3. forouzanfar mh, foreman kj, delossantos am, lozano r, lopez ad, murr...

Fibulin-4, a member of the fibulin family of extracellular glycoproteins, is implicated in the progression of a number of types of cancer. However, the function of fibulin-4 in cervical cancer progression remains unexplored. Fibulin-4 mRNA and protein expression levels in normal cervical tissue, cervical intraepithelial neoplasia (CIN), cervical carcinoma, highly invasive subclones and low-inva...

introduction: certain types of human papillomavrus (hpv) are associated with cervical intraepithelial neoplasia (cin) and squamous cell carcinoma (scc). the aim of theobservations reported here was to determine whether the prognosis for invasive cancers of the uterine cervix is related to the type of human papillomavirus asociated with the tumor. material and methods: twenty patients with invas...

Cervical cancer is the second most common cancer in women worldwide after breast cancer. There are about 500,000 new cases and 250,000 deaths due to cervical cancer each year. Almost all cervical cancer cases (99%) are caused by human papillomavirus (HPV) infection (World Health Organization 2006). In Malaysia, the age standardized incidence rate (ASR) for cervical cancer is 19.7 per 100,000 wo...